Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ACORAMIDIS vs ADALIMUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ACORAMIDIS vs ADALIMUMAB: Safety Overview

Metric ACORAMIDIS ADALIMUMAB
Total FAERS Reports 234 499,856
Deaths Reported 8 21,807
Death Rate 3.4% 4.4%
Hospitalizations 40 108,264
Average Patient Age 79.6 yrs 50.9 yrs
% Female Patients 18.3% 67.6%
FDA Approval Date Nov 22, 2024 N/A
Manufacturer BridgeBio Pharma, Inc. Coherus BioSciences Inc
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription